- Press Release Distribution

Enhanced melanoma vaccine offers improved survival for men

Enhanced melanoma vaccine offers improved survival for men
( A second-generation melanoma vaccine being developed at UVA Cancer Center improves long-term survival for melanoma patients compared with the first-generation vaccine, new research shows. Interestingly, the benefit of the second-generation vaccine was greater for male patients than female patients. That finding could have important implications for other cancer vaccines, the researchers say.

The vaccine developers, led by Craig L. Slingluff Jr., MD, found that they could enhance the effectiveness of their melanoma vaccine by simultaneously stimulating important immune cells known as “helper T cells” to recognize melanoma proteins, in addition to stimulating killer T cells against melanoma. This boosted patient survival and helped prevent reoccurrences of the cancer. 

The researchers are not sure why the approach was more effective in men, but biologic sex is emerging as an important factor in outcomes of patients with melanoma, in particular with immune therapies. The findings support the importance of understanding how best to benefit women and well as men with effective immunotherapies. 

“These findings support the promise of this second-generation melanoma vaccine for prolonging survival of patients after surgery for high-risk melanoma,” said Slingluff, a surgical oncologist and translational immunologist at UVA Health and the University of Virginia School of Medicine. “We hope that we can make this available to patients in addition to other effective immune therapies so that they may have even greater benefit than either treatment alone.”

More Effective Melanoma Vaccine

People commonly think of vaccines as something you take to avoid getting sick from viruses. Most cancers do not have a known viral cause, but melanoma vaccines can induce immune responses against human melanoma cells, and Slingluff and others have been working to make them effective for treatment of melanoma. (There are cancers that are caused by viruses, and some vaccines against those viruses have been very effective at preventing cancers they cause — for example, there are vaccines against human papillomavirus and hepatitis B).  

Slingluff’s melanoma vaccine targets a form of skin cancer that kills thousands of Americans every year. In seeking to make the vaccine more effective, he and his team tested two different approaches to stimulating both CD4+ helper T cells and CD8+ killer T cells in patients with high-risk melanoma. More than 160 clinical trial volunteers were given, at random, one of two vaccine preparations of purified peptides to stimulate their helper T cells. 

Fifteen years after the last participant was enrolled in the trial, overall survival rates were encouraging with both vaccine approaches, but overall survival was better for those with the second-generation vaccine. Those who benefitted most appeared to be younger men with earlier-stage melanoma. The researchers characterize the benefit as “meaningful and durable” in a new scientific paper outlining their findings.

“We were very excited by these findings and for the promise to improve survival with these vaccines,” Slingluff said. “Combination of the second-generation vaccine with other immune therapies may further increase the benefit for patients.”

The multicenter trial’s findings suggest that both age and sex may play important roles in determining immune therapy outcomes. That is important information for doctors and researchers developing these treatments, Slingluff says.

“The differences in benefit based on age and biologic sex highlight the need to understand reasons for those differences so that we can provide the same benefit for all patients,” Slingluff said. “We are excited to build on these exciting findings.” 

Slingluff’s pioneering research is part of UVA Cancer Center’s ongoing mission to develop new ways to treat cancer and improve patients’ cancer treatment options. In recognition of those efforts, the National Cancer Center has named UVA Cancer Center one of only 56 “comprehensive cancer centers” in the country. The designation recognizes elite cancer centers with the most outstanding patient care and research programs in the nation.

Advancing the field of immunotherapy is also a key pillar of UVA’s upcoming Paul and Diane Manning Institute of Biotechnology, now under construction at Fontaine Research Park. The institute is poised to fast track the development of new treatments and cures and transform how healthcare is delivered across the state and beyond.

Findings Published

Slingluff and his team have published their findings in the scientific journal Nature Communications. In addition to Slingluff, the multi-institutional team included Emily K. Ninmer, Hong Zhu, Kimberly A. Chianese-Bullock, Margaret von Mehren, Naomi B. Haas, Merrick I. Ross and Lynn T. Dengel. 

The research was supported by the National Cancer Institute, grants R01CA118386 and P30CA044579; gifts from Alice and Bill Goodwin; and the Commonwealth Foundation for Cancer Research.

Slingluff disclosed that he receives licensing fees for patents for peptides used in cancer vaccines; his work has been supported by Celldex, Glaxo-Smith Kline, Merck, 3M and other companies. A full list of the authors’ disclosures is included in the paper. 

To keep up with the latest medical research news from UVA, subscribe to the Making of Medicine blog.


[Attachments] See images for this press release:
Enhanced melanoma vaccine offers improved survival for men Enhanced melanoma vaccine offers improved survival for men 2 Enhanced melanoma vaccine offers improved survival for men 3


Nearly one-third of patients with TBI have marginal or inadequate health literacy

Waltham — March 26, 2024 — Low health literacy is a problem for a substantial proportion of people with moderate to severe traumatic brain injury (TBI), according to research published in The Journal of Head Trauma Rehabilitation (JHTR). The official journal of the Brain Injury Association of America, JHTR is published in the Lippincott portfolio by Wolters Kluwer.  Angelle M. Sander, PhD, FACRM, Professor in the H. Ben Taub Department of Physical Medicine and Rehabilitation at Baylor College of Medicine and Director of TIRR Memorial Hermann’s Brain Injury Research Center, ...

Genetic causes of cerebral palsy uncovered through whole-genome sequencing

A Canadian-led study has identified genes which may be partially responsible for the development of cerebral palsy.  Cerebral palsy (CP), a condition that affects the development of motor skills in children, is the most common childhood-onset physical disability. CP can have different causes, such as infections, injuries, or lack of oxygen before or during birth, but the genetic contributors to CP have remained largely unknown.  Novel research from scientists at The Hospital for Sick Children (SickKids), the Research Institute of the McGill University ...

Modesty and boastfulness – perception depends on usual performance

Modesty and boastfulness – perception depends on usual performance
When people present themselves as capable or humble, the way this influences other people’s evaluations of one’s true ability and character depends on one’s usual performance. Kobe University and University of Sussex researchers thus add an important factor in our understanding of how the relationship between self-presentation and perception develops with age. People want to be liked. Amongst the many ways of achieving this, making statements about oneself to manipulate other people’s evaluation is called “self-presentation.” Both the ability to do so and the effect this has on others’ evaluation of one’s ability ...

Do sweeteners increase your appetite? New evidence from randomised controlled trial says no 

University of Leeds news  Embargo: Thursday 28 March 2024, 23:30 UK time  Do sweeteners increase your appetite? New evidence from randomised controlled trial says no  Replacing sugar with artificial and natural sweeteners in foods does not make people hungrier – and also helps to reduce blood sugar levels, a significant new study has found.  The double blind randomised controlled trial found that consuming food containing sweeteners produced a similar reduction in appetite sensations and appetite-related hormone responses ...

Women with obesity do not need to gain weight during pregnancy, new study suggests

The guidelines for weight gain during pregnancy in obese women have long been questioned. New research from Karolinska Institutet supports the idea of lowering or removing the current recommendation of a weight gain of at least 5 kg. The results are published in The Lancet. International guidelines from the US Institute of Medicine (IOM) state that women with obesity should gain a total of 5 to 9 kg during pregnancy, compared to 11.5 to 16 kg for normal-weight women. The guidelines have long been questioned, but there has been no evidence to warrant a re-examination. A new study from Karolinska Institutet in Sweden now shows that there are no increased health risks for either the mother or ...

Individuals with multiple sclerosis face substantially greater risk of hospitalisation and death from COVID-19, despite high rates of vaccination

Authors say the findings underscore the urgent need for preventive measures for people with MS who are inadequately protected by COVID-19 vaccination alone. *Please mention the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024, Barcelona, 27-30 April) if using this material* New real-world research being presented at this year’s European Congress of Clinical Microbiology and Infectious Diseases (ECCMID 2024) in Barcelona, Spain (27-30 April) reveals that people living with multiple sclerosis (MS) face a much higher ...

Study shows obesity in childhood associated with a more than doubling of risk of developing multiple sclerosis in early adulthood

New research to be presented at this year’s European Congress on Obesity in Venice, Italy (12-15 May) shows that having obesity in childhood is associated with a more than doubling of the risk of later developing multiple sclerosis. The study is by Professor Claude Marcus and Associate Professor Emilia Hagman, Karolinska Institutet, Stockholm, Sweden, and colleagues. Emerging evidence implies a link between high BMI in adolescence and an increased risk of Multiple Sclerosis (MS). Yet, most studies evaluating this association are cross-sectional, have retrospective design with self-reported data, have used solely genetic correlations, or use paediatric ...

Rice Emerging Scholars Program receives $2.5M NSF grant to boost STEM education

Rice Emerging Scholars Program receives $2.5M NSF grant to boost STEM education
Rice University’s Emerging Scholars Program (RESP) has received a five-year, $2.5 million grant from the National Science Foundation. The funding aims to bolster achievements in science, technology, engineering and mathematics (STEM) among students from under-resourced families and communities. The grant will enable RESP to expand its reach and impact, offering increased support to its scholars via summer tuition scholarships, housing subsidies and research stipends. The number of scholars in the program will increase from 40 to 50 in Summer 2024 and to 60 in Summer 2025. “Rice ...

Virtual rehabilitation provides benefits for stroke recovery

A stroke often impacts a person’s ability to move their lower body from the hips down to the feet. This leads to diminished quality of life and mental health in addition to increased susceptibility to falls. But now, UBC Okanagan researchers are exploring new treatment methods to help bridge the service delivery gap, and recovery outcomes, for patients after a stroke. “Shortened length of inpatient stays and continued challenges in transitioning back to the community—including poor access to continued stroke rehabilitation services—have resulted in substantial unmet recovery needs,” ...

Generative AI develops potential new drugs for antibiotic-resistant bacteria

With nearly 5 million deaths linked to antibiotic resistance globally every year, new ways to combat resistant bacterial strains are urgently needed. Researchers at Stanford Medicine and McMaster University are tackling this problem with generative artificial intelligence. A new model, dubbed SyntheMol (for synthesizing molecules), created structures and chemical recipes for six novel drugs aimed at killing resistant strains of Acinetobacter baumannii, one of the leading pathogens responsible for antibacterial resistance-related deaths. The researchers described their model and experimental validation of these new compounds in a study published March 22 in the journal ...


UK/Portuguese study strongly suggests antibiotic-resistant “superbugs” are being passed from cats and dogs to their owners

Researchers study effects of solvation and ion valency on metallopolymers

Physicists solve puzzle about ancient galaxy found by Webb telescope

Clear guidelines needed for synthetic data to ensure transparency, accountability and fairness study says

Report finds significant gender and racial inequities in the educational measurement profession

University of Houston and Scotland’s Heriot-Watt University forge strategic energy alliance

Rice team demonstrates miniature brain stimulator in humans

Jennifer Stinson receives prestigious Barer-Flood Prize in health services research

First insights into the genetic bottleneck characterizing early sheep husbandry in the Neolithic period

Theories that explain the crisis in democracy are inadequate for Latin America, experts say

Starving cells hijack protein transport stations

Where have all the right whales gone?

Researchers find no link between COVID-19 virus and development of asthma in children

Cell’s ‘garbage disposal’ may have another role: helping neurons near skin sense the environment

Study reveals potential to reverse lung fibrosis using the body’s own healing technique

International team co-led by a BSC researcher discovers more than 50 new deep-sea species in one of the most unexplored areas of the planet

Cleveland Innovation District partners exceeding many targets set by state and JobsOhio

A third of women experience migraines associated with menstruation, most commonly when premenopausal

MD Anderson Research Highlights for April 12, 2024

Soft Robotics appoints new Deputy Editor-in-Chief, Barbara Mazzolai, PhD

Wiley releases Mass Spectra of Designer Drugs 2024 to accelerate forensics analysis of fentanyls, cannabinoids, and more

Freestanding emergency departments are popular, but do they function as intended?

University of Cincinnati experts present at national neurology conference

Bonobos are more aggressive than previously thought

How seaweed became multicellular

Melanomas resist drugs by ‘breaking’ genes

Africa’s iconic flamingos threatened by rising lake levels, study shows

Vaccination timeliness among US children ages 0-19 months

Changes in permanent contraception procedures among young adults following the Dobbs decision

Semaglutide vs endoscopic sleeve gastroplasty for weight loss

[] Enhanced melanoma vaccine offers improved survival for men